Executive Vice President of Customer Delivery Leads Session at DIA 2022 Global Annual Meeting
Horsham, PA, June 8th, 2022 – Megan Petrylak, Executive Vice President of Customer Delivery at Clinical ink, and Jonathan Andrus with Society for Clinical Data Management will be leading the session “Collection of Quality Endpoint Data in a Decentralized Trial in Complex Indications: The Practical and Logistical Challenges” at DIA 2022 in Chicago on Tuesday, June 21st from 11:00-12:00 pm (CDT).
When using sophisticated assessments in clinical research, sponsors must capture both structured and unstructured data – on site and remotely. Using disease-specific decentralized clinical trials as examples, Megan and Jonathan will discuss how remotely deployed data capture technology helps to manage both logistically as well as therapeutically complex clinical trials.
For over 14 years, Petrylak has held various leadership roles within the pharma industry to drive program and operational excellence. At Clinical ink, she leads key organizational initiatives to drive better outcomes for patients.
Visit with the Clinical ink team in Booth #1701 at DIA 2022 to learn how our clinical trial digital data capture solutions power patient outcomes.
About Clinical Ink
Clinical ink is the global life science company that brings data, technology, and patient science together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drive the industry standard for data precision and usher in a new generation of clinical trials. By harnessing digital data, we power sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience
For more than 50 years, DIA has been dedicated to providing a neutral and transparent global forum for the exchange of ideas and collaborations to further scientific and medical innovations. The DIA 2022 Global Annual Meeting brings industry, regulators, academics and patients together to co-create, problem-solve, and discuss global and local challenges facing professionals in the life sciences community.